Beyond Air Inc XAIR
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-05-07 |
| Shares Out. | 720,000 |
| Website | beyondair.net/ ↗ |
| Phone | 15166658200 |
| Employees | 54 |
| Revenue | $1.9M |
| Gross Profit | $94,000 |
| Net Income | -$10.4M |
| Free Cash Flow | -$19.2M |
| Total Assets | $35.4M |
| Total Liabilities | $29.2M |
| Equity | $6.2M |
About Beyond Air Inc
Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.
Beyond Air Inc is a publicly traded company under the ticker symbol XAIR on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-07-01)